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Evidence currently suggests that as a species Mycobacterium tuberculosis exhibits
very little genomic sequence diversity. Despite limited genetic variability, members of
the M. tuberculosis complex (MTBC) have been shown to exhibit vast discrepancies
in phenotypic presentation in terms of virulence, elicited immune response and
transmissibility. Here, we used qualitative and quantitative mass spectrometry tools
to investigate the proteomes of seven clinically-relevant mycobacterial strains—four
M. tuberculosis strains, M. bovis, M. bovis BCG, and M. avium—that show varying
degrees of pathogenicity and virulence, in an effort to rationalize the observed phenotypic
differences. Following protein preparation, liquid chromatography mass spectrometry
(LC MS/MS) and data capture were carried out using an LTQ Orbitrap Velos. Data
analysis was carried out using a novel bioinformatics strategy, which yielded high protein
coverage and was based on high confidence peptides. Through this approach, we
directly identified a total of 3788 unique M. tuberculosis proteins out of a theoretical
proteome of 4023 proteins and identified an average of 3290 unique proteins for
each of the MTBC organisms (representing 82% of the theoretical proteomes), as well
as 4250 unique M. avium proteins (80% of the theoretical proteome). Data analysis
showed that all major classes of proteins are represented in every strain, but that
there are significant quantitative differences between strains. Targeted selected reaction
monitoring (SRM) assays were used to quantify the observed differential expression of
a subset of 23 proteins identified by comparison to gene expression data as being of
particular relevance to virulence. This analysis revealed differences in relative protein
abundance between strains for proteins which may promote bacterial fitness in the more
virulent W. Beijing strain. These differences may contribute to this strain’s capacity for
surviving within the host and resisting treatment, which has contributed to its rapid
spread. Through this approach, we have begun to describe the proteomic portrait of
a successful mycobacterial pathogen. Data are available via ProteomeXchange with
identifier PXD004165.
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INTRODUCTION
Tuberculosis disease is caused by the bacterium Mycobacterium
tuberculosis, and remains one of the leading causes of death by a
single pathogen worldwide. Despite the presence of a vaccine and
a number of antibiotics for the disease, it continues to cause about
2 million deaths and 8 million new cases worldwide per year.
The emergence of multiple and extremely drug resistant strains,
together with HIV co-infection, are fuelling the pandemic-
especially in developing countries. Furthermore, latent and sub-
clinical tuberculosis infection compounds tuberculosis control
strategies by creating an unseen pathogenic reservoir. Even
though various strains of M. tuberculosis have whole genome
sequences available, the bacterium still closely guards the secrets
of its success as a human pathogen.
According to whole-genome analysis, members of the M.
tuberculosis complex (MTBC) exhibit the greatest degree of
genetic conservation above all other pathogenic bacteria (99.9%).
This strict level of observed genetic homogeneity initially led
to the assumption that genetic variety amongst different strains
would not be of any clinical significance (Homolka et al., 2008).
However, subsequent research has led to the understanding that
traits manifested by members of the MTBC are influenced by the
genetic and evolutionary background of the strains (Gagneux and
Small, 2007). Although, thousands of strains have been identified,
only a few seem to drive widespread disease outbreaks and
multi-drug resistance (Bifani et al., 2002).M. tuberculosis isolates
have been observed to exhibit vast discrepancies in phenotypic
presentation especially with regard to clinical outcome and
epidemiological behavior (Shimono et al., 2003; Baker et al., 2004;
Gagneux and Small, 2007; Nicol and Wilkinson, 2008). The East
Asian/Beijing M. tuberculosis lineage is particularly of interest
due to its increasing prevalence in the global TB community,
implying an apparent selective advantage compared to existing
strains (Parwati et al., 2010). It is therefore cause for concern that
modern Beijing lineages appear to be accumulating mutations
which enhance pathogenicity, apparently under positive selection
pressure (Merker et al., 2015). The exactmode bywhich increased
pathogenicity is conferred in this lineage remains undetermined
and is likely to be a combination of factors (Ribeiro et al., 2014),
however some proposed mechanisms include enhanced stress
response, drug resistance and altered host-pathogen interactions,
as has been reviewed previously (Hanekom et al., 2011; Warner
et al., 2015). On the other hand, some closely related strains in
the M. tuberculosis complex (MTBC) have attenuated virulence
in humans (such as the vaccine strain BCG), or are not
typically human pathogens and will only opportunistically infect
immunocompromised humans (Desforges and Horsburgh, 1991;
Wang and Behr, 2014; Halstrom et al., 2015).
Whilst genetic variation across multiple strains has been
studied in depth, the clinical and epidemiological consequences
of genetic differences between mycobacterial strains remains
poorly understood (Malik and Godfrey-Faussett, 2005). As
a consequence, it is not known whether the proteome is
comparatively static between different strains of M. tuberculosis
or whether quantitative differences in the expressed proteomes
could contribute in some way to differential virulence. Here, we
used liquid chromatography mass spectrometry (LC-MS)-based
proteomics to define and compare the proteomic complement
of 6 clinically relevant mycobacterial strains within the MTBC
as well as a strain of Mycobacterium avium as an outlier.
While these strains are all pathogenic in principal, the extent
to which they cause disease in humans varies greatly. We
therefore aimed to identify protein expression profiles that
might correlate with altered virulence amongst these strains
by comparing more pathogenic strains in the MTBC to less
pathogenicMycobacterium bovis, BCG andM. avium strains.
MATERIALS AND METHODS
M. tuberculosis isolates H37Rv, W-Beijing, CAS and LAM3
were obtained from the Medical Microbiology Division of the
University of Cape Town. The clinical strains representing
lineages 2 (Beijing), 3 (CAS), and 4 (LAM3/F11) were isolated
from pediatric patients from Red Cross war memorial hospital,
Cape Town. M. tuberculosis H37Rv was used in all assays as
a reference strain. Phylogeny of the isolates was determined
using spoligotyping and MIRU-VNTR described in Sarkar et al.
(2012) and is shown in Supplementary Table 1. The Danish
strain of M. bovis BCG was used in this study. The M. avium
strain was obtained from theNational Health Laboratory Services
(NHLS) laboratory and was verified using line probe assays. M.
bovis was obtained from Stellenbosch University Health Sciences
Department in Tygerberg Hospital, Cape Town.
Cell Culture
Cells were maintained in wholly synthetic Sautons media (2%
glycerol, 0.4% L-asparagine, 0.2% glucose, 0.2% citric acid, 0.05%
mono-potassium phosphate, 0.05% magnesium sulfate, 0.015%
Tween 80, 0.005% ferric citrate, 0.00001% zinc sulfate at pH 7.4).
Briefly, 190 ml of Sautons medium was inoculated with a 10 ml
starter culture (approximately 108 bacteria/ml). The flasks were
sealed and incubated at 37◦C and 5% CO2 with gentle agitation
until OD600 reached 0.9 (approximately 6 weeks).
Protein Extraction
Proteins were extracted in a Biosafety level 3 facility in line with
health and safety guidelines. Briefly, the cell pellet was separated
from the culture filtrate by centrifugation at 4000 × g for 15min
in a bench-top centrifuge. Cell lysis was carried out by boiling
the cell pellet in 1% SDS buffer (1% SDS, 100mM Tris-HCl pH
7.6, 0.1mM dithiothreitol (DTT), 1 mM PMSF) for 30min. Cell
debris was separated from the protein containing supernatant by
centrifugation at 10,000× g for 15min in a bench top centrifuge
and the supernatant containing the protein was transferred into
a clean tube. Protein extracts from cell lysates were concentrated
and buffer exchanged to 2M urea buffer using 3 kDa MWCO
filters (Millipore). Culture filtrate proteins were concentrated
and buffer exchanged into 2M urea using 15ml 10 kDa MWCO
filters. Protein concentration was determined using the BCA
assay kit (Thermo Scientific). A 10 kDa MWCO filter was used
for the culture filtrate instead of a 3 kDa because this is the
lowest filter size available for large volumes, however, according
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to manufacturer’s product specifications (Millipore), proteins as
low as 3 kDa are still retained on 10 kDa MWCO filters.
Protein Separation (1D SDS PAGE)
Proteins were separated according to molecular weight using
an SDS PAGE gel system. The separating gels were made from
10% acrylamide: bis-acrylamide, 0.375M Tris-HCl (pH 8.8),
7.5% SDS, 0.5% ammonium persulphate and 0.1% TEMED. The
stacking gels consisted of 4% acrylamide: bis-acrylamide, 0.125M
Tris-HCl (pH 6.8), 0.1% SDS, 0.5% ammonium persulphate
and 0.1% TEMED. 40 µg of each sample (culture filtrate and
intracellular protein) was mixed with an equal volume of 2x
sample buffer and heated at 65◦C for 5min. Electrophoresis was
performed from anode to cathode at 100V using a BioRad mini-
Protean II gel system until the bromophenol blue dye reached the
bottom of the gel.
Protein Visualization
Visualization of the proteins on the gel was performed using
Coomasie brilliant blue R250 for 1 h (50% methanol, 10% acetic
acid and 0.1% Coomasie brilliant blue R250). Destaining of the
gels was carried out by incubating on a shaker overnight at room
temperature in destaining solution (10% methanol, 10% acetic
acid).
In Gel Trypsin Digestion
Each gel lane for each strain sample was divided into 5 pieces (i.e.,
5 culture filtrate fractions and 5 intracellular protein fractions,
hence a total of 10 fractions per strain). Each gel piece was cut
into smaller cubes and washed twice with water followed by
50% (v/v) acetonitrile for 10min. The acetonitrile was replaced
with 50mM ammonium bicarbonate and incubated for 10min.
Washes with 50mMammonium bicarbonate were repeated twice
to remove acetonitrile. All the gel pieces were then incubated
in 100% acetonitrile until they turned white, after which the gel
pieces were dried in vacuo. Proteins were reduced with 10mM
DTT for 1 h at 57◦C. This was followed by brief washing steps
of ammonium bicarbonate followed by 50% acetonitrile before
proteins were alkylated with 55mM iodoacetamide for 1 h in
the dark. Following alkylation, the gel slices were washed with
ammonium bicarbonate for 10min followed by 50% acetonitrile
for 20min, before being dried in vacuo. The proteins in the gel
cubes were digested with trypsin (Promega) at 37◦C overnight in
a 1:50 trypsin: protein ratio. The resulting peptides were extracted
twice with 70% acetonitrile in 0.1% formic acid for 30 min and
then dried and stored at −20◦C. Dried peptides were dissolved
in 5% acetonitrile in 0.1% formic acid and 10 µl injections were
made for nano-LC chromatography.
Mass Spectrometry
All experiments were performed on a Thermo Scientific EASY-
nLC II coupled to an LTQ Orbitrap Velos mass spectrometer
(Thermo Scientific, Bremen, Germany) equipped with a nano-
electrospray source. For liquid chromatography, separation was
performed on an EASY-Column (2 cm, ID 100 µm, 5 µm, C18)
pre-column followed by a, EASY-column (10 cm, ID 75 µm, 3
µm, C18) column with a flow rate of 300 nl/min. The gradient
used was from 5–15% B in 5min, 15–35% B in 90min, 35–60%
B in 10min, 60–80% B in 5min, and kept at 80% B for 10min.
Solvent A was 100% water in 0.1% formic acid; solvent B was
100% acetonitrile in 0.1% formic acid. MS/MS data was acquired
from the Orbitrap Velos in Top 20 CID mode.
Post MS Data Analysis
Raw data was captured from the mass spectrometer and
converted to MS2 files using MakeMS2 software (Thermo
Scientific). The data was then analyzed using Crux (McIlwain
et al., 2014) and Mascot (Cottrell and London, 1999), and the
output of MS2PIP (Degroeve and Martens, 2013) was used
additional features for the Percolator algorithm. Spectra were
obtained from each fraction of the gel (a total of 5 fractions per
strain) and were viewed using Peaks v5.3. The mass spectrometry
proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE (Vizcaíno et al., 2016) partner
repository with the dataset identifier PXD004165.
Protein Preparation for SRM-MS
Proteins were extracted in the BSL3 facility in line with health
and safety guidelines as described in Section Protein extraction.
Protein concentration was determined using a BCA assay
according to manufacturer’s protocol (#23227, Thermo Fisher
Scientific). Protein preparation was performed using a filter
aided sample preparation (FASP) method. Briefly, 200 µg of
each protein sample was placed into a 10KDa molecular weight
cut off filter (MWCO) (Millipore). Protein cysteine residues
were alkylated in the dark for 30min in 10mM iodoacetamide.
Iodoacteamide was then removed by centrifugation at 14,000 ×
g for 15min. Buffer exchange was performed twice with 8 M urea
in 0.1mM Tris-HCl pH 8.5 by centrifugation at 14,000 ×g for
15min in a refrigerated bench-top centrifuge at 18◦C. The urea
buffer was then exchanged for 0.05M ammonium bicarbonate
by centrifugation. Sequencing-grade modified trypsin (#608-274-
4330, Promega) was added at a ratio of 1:100 enzyme: substrate
and incubated overnight at 37◦C in a wet chamber. The peptides
were finally collected through the filter into a clean collection
tube by centrifugation at 14 000× g for 10min.
To stop the tryptic digest the pH was lowered to 2 using
50% trifluoro acetic acid (TFA) followed by an incubation for
15 min at 37◦C with shaking at 500 rpm. The peptide solution
was desalted with C18 reversed-phase columns (Pierce #89870-
25) according to the manufacturer’s instructions. Briefly, the
C18 columns were activated with 50% methanol, followed by
equilibration with 5% ACN: 0.5% TFA. After loading the sample,
the columns were washed 3 times with 5% ACN: 0.5% TFA.
Finally, peptides were eluted with 70% ACN, dried under
vacuum, and re-solubilized in 0.1% FA to a final concentration
of 8 µg/µl.
SRM Mass Spectrometry
All SRM experiments were performed on a TSQ Vantage
triple quadrupole mass spectrometer (Thermo Fisher Scientific)
equipped with a heated electrospray II ion source. For liquid
chromatography and separation of peptides, a Synergi 4 µHydro
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RP 150 × 4.60mm 80 Å pore size C18 column (serial # 630710-
14) was used with a column flow rate of 300µl/min. The gradient
used was from 5–15% B in 5min, 15–35% B in 90min, 35–60%
B in 10min, 60–80% B in 5min and kept at 80% B for 10min.
Solvent A was 100% water in 0.1% formic acid, and solvent B was
100% acetonitrile in 0.1% formic acid.
The mass spectrometer was operated in positive mode using
electrospray ionization with a voltage of 3500V. The capillary
temperature was set to 350◦C and the collision gas pressure to
1.2 mTorr. Up to 336 transitions per run were acquired with a
cycle time of 3 s and a dwell time of at least 20ms. Collision
energies were calculated per individual peptide transition ion
using Skyline software and further optimized by a series of
energy ramping experimental steps (10 steps of 5V) to obtain the
optimum energy of each transition. MS/MS data was acquired
from the CID mode. Raw data was captured from the mass
spectrometer and analyzed using Skyline software.
The proteins chosen for SRM analysis were based on relevance
in pathogenicity and/or virulence as stated in literature as shown
in Supplementary Table 2. To design SRM assays, peptides
were chosen for analysis based on their prior observation in
our discovery experiments. Although, each protein was typically
observed by two or more peptides in the discovery experiment,
the two best performing peptides were chosen to confirm each
protein in the SRM assay, with the exception of 2 proteins
(Rv1818c and Rv0833) (Supplementary Table 3). Due to the small
size and non-redundant nature of the M. tuberculosis proteome,
3 ion transitions were set as the minimum number required to
identify a peptide in an SRM assay.
SRM Data Analysis
Data analysis was carried out using Skyline software (MacCoss
Lab software). Intra-assay ambiguity (CV) for each peptide was
based on the calculated average protein concentration for a set of
technical duplicate injections of each sample. Inter-assay CV was
calculated for each peptide from across three biological replicates
of the 7 strains. Quantitation of each peptide was carried out
using the area under the curve for the peptide transitions
assayed in Skyline. Retention times for the peptide standards
were obtained by pre-assessment on theMS. For peptides without
standards, the retention times were obtained from predictions
made by Skyline software and gated at 5 s from the predicted
retention time.
Protein Inference
The protein databases used to generate theoretical spectra were
strain specific individual non-redundant fasta files obtained
from Ensembl (www.ensembl.org), with the exception of LAM
for which there is no Ensembl annotation, and W-Beijing
whose annotated file is not sufficient for downstream cross
strain comparison. For LAM, the UniProt fasta file was used
(www.uniprot.org) and for W-Beijing, the H37Rv Ensembl fasta
file was used. The parameters were standard across both searches
and included carbamidomethylation of cysteine residues as a
fixed modification and oxidation of methionine residues as a
variable modification. Two missed cleavages were allowed and
peptide mass tolerance was set at 10 ppm whilst fragment mass
tolerance was set to 0.5 Da. Decoy databases were used for FDR
analysis and a cut-off was set at 5% for protein identifications.
The PSMs obtained from the search were used to predict the
expressed protein repertoire of each sample. MS/MS spectra from
the 10 fractions per strain were searched with each individual
search engine. Combining results from multiple search engines
yields higher protein identifications (Shteynberg et al., 2013), and
therefore all the proteins identified from each individual search
engine were combined and redundancy was removed to give one
complete non-redundant dataset per study organism.
RESULTS
Total protein extracts from the discovery MS approach were
quantified using BCA assay with concentrations ranging between
2.5–15 µg/µl for total cellular proteins and 10–40 µg/µl for
culture filtrate proteins. Each tryptically digested sample was
analyzed on the Orbitrap Velos to produce an LC-MS and
MS/MS dataset. To assess the efficiency of the tryptic digest a
descriptive analysis software package in Protein Pilot was used
and the results are summarized in Supplementary Table 4.
As shown in Supplementary Figure 1A, the MS1 scan of
H37Rv confirms a successful tryptic digest with the total ion
chromatogram in showing a steady elution of peptides across
the LC gradient. The 2D MS chromatogram (Supplementary
Figure 1B) demonstrates the complexity of the sample, showing
a significant number of discrete tryptic peptides eluting at
the marked time point indicated on the 1D chromatogram
(∼2600 s).
For the analysis of the MS2 spectra a software pipeline
was implemented that combines the results of different peptide
identification strategies. At the core of our pipeline is the
semi-supervised learning algorithm implemented in Percolator
(Brosch et al., 2009) that has been shown to obtain high
identification sensitivity. The first tool in the pipeline is
Crux (McIlwain et al., 2014) which is a reimplementation of
the popular tool Sequest with added post-processing by the
Percolator algorithm. The second tool is Mascot (Cottrell and
London, 1999) for which again Percolator was used to post-
process the MOWSE identification scores1.
The Percolator tool allows for adding new features that
can be exploited by the semi-supervised learning algorithm to
further increase peptide identification sensitivity. It has been
shown that adding features obtained from MS2 peak intensity
predictions can significantly increase sensitivity (Sun et al.,
2007). Therefore, we employed the MS2PIP (Degroeve and
Martens, 2013) tool to predict the b- and y-ion peak intensities
for all peptides suggested by Mascot (top ranked peptide for
each MS2 spectrum). We then computed several features
from the difference between the predicted and the observed
MS2 peak intensities, such as the Pearson correlation. We
observed that adding these features to the Percolator algorithm
for Mascot did indeed increase identification sensitivity
significantly.
1http://www.sanger.ac.uk/science/tools/mascotpercolator
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Comparison of protein numbers obtained at 1% and 5% FDR
showed that the use of 5% FDR allows a substantial increase in the
absolute number of true positives with an insignificant increase
in the absolute number of false positives, hence providing an
apparently favorable trade-off in true positives over false positives
(Figure 1). The final proteome obtained from each strain using
all algorithms represented a high proportion of the theoretical
protein fasta files for each strain, as shown in Table 1.
FIGURE 1 | (A) The contribution of each of the search engines to the total
number of non-redundant proteins obtained per strain at 5% FDR. Mascot is
shown in blue bars, Crux is shown in red bars, Mascot+MS2PIP+Percolator is
shown in green bars and the total non-redundant library is shown in purple
bars. (B) The comparison between 1 and 5% FDR across all strains. This
illustrates the total number of proteins obtained for each strain at each FDR,
and the proportion of true and false positives in that FDR bracket.
TABLE 1 | Total non-redundant number of proteins obtained in the
experiment compared to the total number of proteins in the theoretical
fasta file.
Strain Total # proteins
in fasta file
Total # detected
experimentally
(5% FDR)
% of total
theoretical
proteome found
M. avium 5314 4250 80
M. tuberculosis H37Rv 4049 3539 87
M. tuberculosis Beijing 4049 3224 80
M. tuberculosis CAS 4049 2746 68
M. tuberculosis LAM 3904 3500 90
M. bovis BCG 4041 3272 81
M. bovis 4001 3461 87
Data Alignment for Downstream
Comparison
To carry out an effective cross strain comparison, it was crucial
to ensure that as much of the theoretical proteome as possible
was observed by discovery MS. After obtaining a non-redundant
dataset for each strain using strain specific databases, it became
necessary to convert all the protein IDs into a standard protein ID
by orthology mapping to allow effective cross strain comparison.
To achieve this, the total non-redundant IDs from each strain
obtained by searching against its individual Ensembl fasta file
were then mapped back to the Ensembl H37Rv protein IDs.
These were all in turn mapped to UniProt accession numbers
and Tuberculist “Rv” loci numbers to facilitate downstream
analysis with tools such as GO analysis and pathway mapping.
It was observed that there is a slight deficiency in ortholog
mapping data between databases (Ensembl and UniProt), as well
as shortcomings in ortholog mapping between strains. These
discrepancies lead to a minor loss of information, as represented
in Figure 2. The discrepancy in ortholog mapping was much
more pronounced when mapping protein IDs to H37Rv from
the more distantly related M. avium, which lies outside the
MTBC group; this resulted in loss of approximately 50% of the
biological information in downstream comparisons toM. avium.
Other strains showed relatively small losses in the number of
experimentally observed proteins mapped to H37Rv orthologs,
for instance the LAM strain had approximately 600 proteins with
no orthologs in H37Rv which were therefore not included in the
cross-species comparison.
Qualitative Cross Species Comparison
With congruent IDs, strains were cross-compared to obtain
a comprehensive qualitative comparison as summarized in
Figure 3 using the Venn diagram tool Venny [267]. Protein IDs
from the 4 Mycobacterium tuberculosis strains were compared
(Figure 3A) and, as expected, the majority of observed proteins
were found to be shared amongst all M. tuberculosis strains,
with less than 5% being strain specific. A total of 1938 proteins
comprise the shared proteins among the 4M. tuberculosis strains,
perhaps representing a M. tuberculosis core proteome. A second
diagram was generated comparing the collective, non-redundant
proteomes of the four M. tuberculosis strains to those of M.
bovis, BCG, M. avium (Figure 3B). Surprisingly, M. avium had
many proteins in common with the MTBC strains, with only 12
unique proteins apparently unique toM. avium; this may simply
reflect though the deficiencies in ortholog mapping between
more distantly related organisms. The fourM. tuberculosis strains
also share 989 common proteins with M. bovis and BCG which
they do not share with M. avium. A group of 168 was observed
uniquely in theM. tuberculosis strains and not found inM. bovis,
BCG or M. avium; these proteins were therefore earmarked as
candidate virulence factors to be further explored.
Protein Expression Profiling
We subsequently sought to quantitatively assess a subset of the
candidate virulence factors identified by discovery MS and cross-
strain comparison using selected reaction monitoring (SRM)—
a sensitive, reproducible and quantitative MS technique. Since
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FIGURE 2 | The losses in number of identified proteins obtained after
experimental ortholog mapping to M. tuberculosis H37Rv for each
strain. Avium—Mycobacterium avium, H37Rv—Mycobacterium tuberculosis
H37Rv, Beijing—Mycobacterium tuberculosis W. Beijing,
CAS—Mycobacterium tuberculosis CAS, LAM—Mycobacterium tuberculosis
LAM, BCG—Mycobacterium bovis BCG, Bovis—Mycobacterium bovis.
the design of SRM robust assays can be a lengthy process
and the capacity to highly multiplex hundreds of SRM assays
remains challenging, we devised a strategy to create a short
list of candidate proteins with possible relevance in differential
clinical phenotypes observed between theM. tuberculosis isolates
for subsequent quantitative proteomic analysis. To do this, we
compared our proteomic data on each of the 168 proteins
(Supplementary Table 5) that were observed only in the M.
tuberculosis strains with 771 gene expression data sets contained
in the TBDB, representing varying in vitro models of TB
disease. We focussed attention in particular on 7 categories of
experiment from the TBDB that aimed to more closely reflect
in vivo conditions (e.g., starvation models, macrophage infection
models, hypoxic models, etc.), the logic being that consistent
over-expression of a protein in one of those categories might
plausibly confer a selective advantage to the bacterium in vivo;
the categories chosen are listed in Table 2.
For each of the 168 proteins, we assessed whether they were
significantly over- or under-expressed in each of the 7 chosen
categories of gene expression models and carried out statistical
analysis on the gene expression values obtained from the TBDB
experiments using packages in R (strategy depicted in Figure 4).
Proteins from the 168 protein set whose gene expression showed
an average fold change of ≥2 SD from the mean across all
datasets in an individual condition were taken as significantly
differentially expressed in that condition. Proteins that had
significant fold change for fewer than 4 out of the 7 categories
were removed from this list, resulting in a final shortlist of 23
proteins, summarized in Table 3. In order to create SRM assays
for the shortlisted proteins, the M. tuberculosis proteome library
(Schubert et al., 2013) was consulted and validated SRM assays
for the proteins of interest were extracted.
A minimum of 2 peptides per protein and 3 transitions
per peptide were assessed by SRM for the shortlisted proteins
in all seven strains. Intra-assay and inter-assay coefficients of
variation were determined for each individual peptide. Intra
FIGURE 3 | Qualitative cross strain/species data analysis. (A) Venn
diagram showing the overlap in the numbers of protein identifications between
the 4 strictly Mycobacterium tuberculosis strains CAS, LAM, W-Beijing, and
H37Rv. (B) Venn diagram representing the comparison between the collective
non-redundant proteins obtained in the 4 strictly M. tuberculosis strains (CAS,
LAM, W-Beijing, and H37Rv) denoted “Human clinical strains” and those of M.
bovis, BCG, and M. avium.
TABLE 2 | The number of significantly differentially expressed proteins
from the 168 proteins unique to human clinical strains segregated into
over- or under-expressed per category assessed (www.tbdb.org).
TBDB Experiment Over-expressed Under-expressed
Acid media 58 38
Macrophage 18 53
Hypoxia 59 49
NO treatment 78 32
Starvation 51 26
Persistence 23 43
Antibiotics 40 54
assay variability was based on 3 technical replicates per strain
whilst inter assay variability was assessed based on 2 biological
replicates. The signal of each peptide observed was obtained by
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FIGURE 4 | Gene expression analysis approach of the short list of 168 proteins expressed in human clinical strains. Expression ratio data was obtained
from the chosen TBDB experiments and statistical packages in R were used to convert the ratios into fold changes. Analysis of the fold changes was done in R to
indicate proteins that have significant fold changes (≥2 from the mean) which are shown in the scatterplot above and below the shaded area.
summing the peak areas of each measured transition for that
peptide and then normalizing by the total number of cells per
strain at the point of protein extraction. AnANOVA test was used
to determine if there was a significant difference in the expression
of each of the peptides representing each protein. The single
factor ANOVA results (Table 3) shows that of the 23 peptides
assessed, 18 had a significant difference in expression between
the 7 strains. The proteins were then broadly classified into 4
groups denoting some aspect of the organisms’ success in the host
(Supplementary Figure 2) in order to aid further interpretation of
the data.
The four proteins assayed with roles in drug response are
PyrB, PyrC, CarA, and CarB, and all form part of the pyrimidine
biosynthetic operon in M. tuberculosis. All with the exception
of carB (Rv1384) are more abundant in M. avium compared to
the other strains, but within the MTBC the Beijing strain has the
highest expression of PyrB, PyrC, and CarA.
Amongst proteins which are known to modulate the host
immune response, the uncharacterized hypothetical protein
Rv0966 is highly expressed in the LAM strain compared to
the other strains. In this functional category, Rv2136c, Rv1002,
Rv2703, and Rv2108 are more abundant in the Beijing strain.
Rv1818c appears to be more abundant in the CAS strain while
in the other strains it is present at comparatively low amounts.
Amongst proteins responsible for the growth of M.
tuberculosis in the host, a possible toxin with unknown
function, VapC2 (Rv0301), has the highest relative expression
in the Beijing strain. PE_PGRS13 (Rv0833), MetC (Rv3340),
and conserved hypothetical protein Rv3412 are all more
abundant in the LAM strain than in BCG orM. avium, although
similarly highly abundant in H37Rv and M. bovis. PPE65
(Rv3621c) appears to be upregulated in both LAM andM. avium
strains.
In terms of adaptation to stress, the Acyl-CoA dehydrogenase
MbtN (Rv1346) is particularly abundant in the Beijing strain.
The protein Rv0901 is apparently less abundant in M. bovis
and BCG strains whereas it is relatively abundant in the other
strains, particularly so in H37Rv and M. avium. Aspartate
kinase (Rv3709c) is more abundant in H37Rv and LAM strains
comparatively, and almost entirely absent in M. avium and
M. bovis.
The contribution to total signal detected for each protein as
measured by SRM in each of the 7 strains is represented in
Figure 5. This analysis demonstrates that proteins which were
detected in a particular strain in the discovery experiment, e.g.,
Rv0301 and Rv1002c which were observed only in the Beijing
strain, tend to contribute the highest signal when measured by
SRM. This appears to be clearly the case for 14 of the 23 proteins
assessed (Rv0301, Rv1381, Rv1383, Rv1002c, Rv3709c, Rv1346,
Rv3412, Rv2108, Rv3621, Rv0833, Rv0966c, Rv1818c, Rv2136c,
and Rv3340).
DISCUSSION
Although, genetically similar, different strains of M. tuberculosis
present very different clinical phenotypes in terms of virulence.
We therefore postulated that there may be a proteomic
mechanism underpinning the differences in pathogenicity
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TABLE 3 | The 23 mycobacterial proteins identified in discovery proteomic experiments which were subsequently selected for quantitative targeted
proteomic analysis.
Rv locus Function and prediction from gene expression data p-value
Rv0301 VapC2; toxin; possible mRNAse; impaired growth when expressed | macrophage infection models 6,75E-07
Rv0899 ArfA; outer membrane porin A; tolerance to acidic conditions, impaired growth at pH 5.5 5,55E-08
Rv0901 ArfC; unknown function; tolerance to acidic conditions, impaired growth at pH 5.5 6,42E-06
Rv0966 Unknown function; highly activated in the early stages of tuberculosis blood brain barrier invasion (CNS TB) 1,96E-05
Rv1002c Pmt; probable mannosyltransferase; conserved membrane protein growth and survival in host 9,35E-07
Rv1346 MbtN; mycobactin biosynthesis; adaptation to intracellular environment | stress response models 0,020716
Rv1380 PyrB; pyrimidine biosynthesis; essential for growth; high confidence drug target | drug response models 0,039441
Rv1381 PyrC; pyrimidine biosynthesis; growth and survival in host | drug response models 4,59E-09
Rv1383 CarA; pyrimidine biosynthesis; growth and survival in host | drug response models 1,08E-06
Rv1384 CarB; pyrimidine biosynthesis; growth and survival in host 4,47E-09
Rv1980c Mpt64; Unknown function; tolerance to starvation, highly immunogenic; vaccine and drug target potential 0,422015
Rv1997 CtpF; Metal cation-transporting ATPase; implicated in dormancy/persistance, response to hypoxia, NO 6,10E-06
Rv2108 PPE36; unknown function; immuno-active membrane component; diagnostic and vaccine target 0,876293
Rv2126c PE_PGRS37; unknown function; possible virulence/adaptation 0,988059
Rv2136c UppP; undecaprenyl pyrophosphatase; high confidence drug target | host immune evasion and virulence models 5,32E-12
Rv2156 MraY; peptidoglycan biosynthesis; growth and survival in host, high confidence drug target 0,97868
Rv2703 SigA; primary sigma factor in M. tuberculosis; host immune response modulator, virulence, growth in host, high confidence drug target |
host immune evasion and virulence models
0,026023
Rv3340 MetC; methionine biosynthesis; growth and survival in host 0,649041
Rv3412 Unknown function; hypothetical protein; essential for cholesterol metabolism, essential during infection 3,27E-07
Rv3621c PPE65; unknown function; possible virulence/adaptation 0,035777
Rv3709c Ask; asparate kinase; survival in host 1,23E-05
Rv1818 PE-PGRS33; unknown function; modulation of host immune response, response to oxygen and starvation 1,61E-06
Rv0833 PE_PGRS13; unknown function; possible virulence/adaptation 9,79E-08
FIGURE 5 | Comparison of relative protein quantity per strain for the 23
mycobacterial proteins as determined by SRM. Each color in the stacked
bar represents the percentage contribution of that strain to the total detected
amount of each protein.
observed between strains of M. tuberculosis and we explored
this possibility using discovery and targeted mass spectrometry
techniques. In order to reveal candidate proteins that might
be involved in differential pathogenicity, we aimed to compare
proteomes between individual pathogenic and non-pathogenic
mycobacteria, noting that both BCG and M. avium can
cause TB-like disease in immune compromised individuals,
suggesting that their pathogenicity is attenuated, not lost
entirely. To underpin our intended cross-strain and cross-
species proteomic comparisons, we first carried out an exhaustive
mass spectrometry-based discovery proteomics analysis of
the 7 mycobacterial strains. Through use of a sophisticated
bioinformatic strategy, combining data from multiple search
engines, we obtained>80% coverage at the protein level for 6 out
of the 7 theoretical proteomes. Combining data across the 4 M.
tuberculosis strains, we identified a total of 3788 M. tuberculosis
proteins with high confidence, meaning that we failed to observe
only 235 out of the predicted 4023 proteins in theM. tuberculosis
proteome. To our knowledge, this level of discovery proteomic
coverage acrossmultipleM. tuberculosis strains is unprecedented,
although we note that recently reported SWATH-based analyses
onM. tuberculosisH37Rv have come close to this figure (Schubert
et al., 2015). Surprisingly, although the 23 proteins subsequently
quantified by SRM were initially observed only in the M.
tuberculosis strains by discovery MS analysis, they were in
fact all identified in all 7 strains by SRM analysis, albeit with
relative quantifications that correlated to a large degree with our
discovery data. Furthermore, SRM analysis of 45 predicted M.
tuberculosis proteins that had not been observed in our discovery
MS analysis of any of the 7 mycobacterial strains revealed that
half were in fact expressed in each of the M. tuberculosis strains
(data not shown), presumably reflecting low absolute expression
levels for those proteins, below the detection limit for discovery
MS. Taken together, our data suggests that the total expressed
complement of proteins is remarkably similar in the different
clinical strains of M. tuberculosis and moreover that virtually
the entire M. tuberculosis proteome is expressed in all strains,
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at least under optimal in vitro conditions. However, our data
also clearly demonstrates that significant, quantitative differences
in expression levels exist between strains which may directly
influence the phenotype of these strains. While it is possible that
protein quantity does not track with the enzyme activity of that
protein in a cell, due to allosteric effects or post-translational
modifications, enzyme activity was not measured in our
study.
Cross-strain and cross-species comparisons of our semi-
quantitative discovery proteomics data were limited only by
the relatively poor ortholog mapping found between M. avium
and M. tuberculosis H37Rv and enabled identification of 168
proteins that were originally observed only in theM. tuberculosis
strains and were therefore considered candidates that might
contribute to the differential virulence of these mycobacterial
strains. However, we were conscious that our proteomic data
had been generated under one set of culture conditions that
were likely far removed from the true host environment in TB
disease. We therefore cross-correlated our proteomic data with
771 gene expression models deposited in the TBDB, covering a
wide range of different in vitro culture conditions and exogenous
stresses on M. tuberculosis that can be thought of as mimicking
various aspects of the host environment (e.g., macrophage
infection; hypoxia; starvation; etc.). The genes for 23 of the 168
proteins were found to be significantly up- or down-regulated in
macrophage-based and related in vitro gene expression models
of TB disease and we therefore carried out quantitative analysis
of their protein expression in vitro across the 7 strains, focussing
particularly on differential expression in the Beijing and LAM
lineages that are known to have particularly virulent clinical
phenotypes (Pillay and Sturm, 2007; Cowley et al., 2008).
One of M. tuberculosis’s many features as a pathogen is its
ability to evade the host innate and acquired immune responses
such that it is capable of attaining latency and can potentially
remain relatively quiescent in alveolar macrophages for decades
(Flynn and Chan, 2003). Here, we identified four proteins which
modulate the host immune response which are significantly more
abundant in the Beijing strain compared to other strains andmay
therefore have functional significance in conferring virulence in
M. tuberculosis—Rv2136c, Rv1002c, Rv2703, and Rv2108.Mutant
M. tuberculosis with insertionally inactivated Rv2136c, a known
virulence factor of the MTBC (Forrellad et al., 2013), has severe
hypersensitivity to acid and a number of other stresses (Vandal
et al., 2009). Rv2136c (uppP) is an undecaprenyl pyrophosphate
phosphatase which recycles undecaprenyl pyrophosphate back
to undecaprenyl phosphate so that it can act again as a
receptor for the UDP-MurNAc-pentapeptide to make C55-
PP-MurNAc-pentapeptide (lipid 1). The antibiotic Bacitracin
inhibits peptidoglycan synthesis by sequestering undecaprenyl
diphosphate, thereby reducing the pool of lipid carrier available,
whilst increased expression of uppP provides resistance; by
extension, Rv2703c might therefore be involved in virulence by
speeding up the recycling of key lipid intermediates and hence
cell wall biosynthesis, thus conferring a selectable advantage on
the virulent Beijing strains. Similarly, sigma factor A (sigA),
Rv2703, is the primary sigma factor in this bacterium and
is essential for growth. Increased initiation of transcription,
and thus RNA processing capacity, may therefore be another
mechanism by which this strain has achieved hypervirulence,
perhaps coupled to the observed increased expression of several
proteins involved in pyrimidine biosynthesis (pyrB, pyr C, CarA).
Although the function of Rv1002c is unknown, it is essential for
growth in H37Rv (Sassetti et al., 2003), whereas the PPE family
protein PPE36 (Rv2108) has no known function and is non-
essential for growth in H37Rv. Both of these proteins therefore
represent attractive targets for further investigation.
Once inside the host macrophage, M. tuberculosis becomes
dependent on the intracellular environment for sources of carbon
(McKinney et al., 2000; Eisenreich et al., 2010) and iron. The
acyl-CoA dehydrogenase, MbtN (Rv1346), is involved in the
production of mycobactins which are thought to be vital for
the acquisition of iron within the macrophage and are therefore
considered to be virulence factors (De Voss et al., 2000). It
is notable therefore that MbtN protein was significantly more
abundant in the Beijing strain, suggesting that this strain’s
capacity to acquire iron intracellularly may be superior. The
capacity to produce essential amino acids in the host may
also provide a selective advantage in terms of virulence, as
demonstrated by the increased relative abundance of the O-
acetylhomoserine sulfhydrylase MetC (Rv3340) and aspartate
kinase Ask (Rv3709c) in the LAM strain.
Another important feature of intracellular M. tuberculosis
in the persistent phase is the toxin/antitoxin system, of which
M. tuberculosis has a remarkable 79 encoded loci (Sala et al.,
2014). Here we found that the possible toxin VapC2 (Rv0301)
was significantly more abundant in the Beijing strain than other
clinical strains. Vap C has been reported to suppress translation
by hydrolysis of mRNA, so its increased expression in the Beijing
strain may represent an evolutionary advantage by providing an
efficient means to erase previous transcriptional profiles, thus
allowing M. tuberculosis to rapidly reprogram the proteome and
hence change the metabolic state of the cell in response to rapidly
changing external stresses during the bacterium’s host-based
lifecycle.
Finally, proteins with unknown function are clear targets for
further investigation—for example the PE_PGRS and PPE family
proteins which are known virulence factors yet currently have no
functional categorization. Both PE_PGRS13 (Rv0833) and PPE65
(Rv3621c) as well as conserved hypothetical proteins Rv0966 and
Rv3412 are abundant in the LAM strain. Interestingly, Rv0901—
a possible exported or membrane protein with unknown
function—is abundant in all measured strains except forM. bovis
and BCG, both of which have attenuated pathogenicity. The loss
of this protein could therefore alter the pathogenicity of the
bacterium, indicating that this protein is a potential therapeutic
target.
An important caveat for any quantitative in vitro study
on M. tuberculosis that aims to correlate gene or protein
expression levels with in vivo clinical phenotypes is that
significant differences in expression observed under specific
in vitro conditions may not accurately reflect the situation
at the site of disease due to altered environmental influences
on expression. This is further compounded by the fact that
it is not currently technically possible to isolate sufficient M.
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tuberculosis bacilli from the site of disease in a human lung
for a discovery proteomics experiment and by the fact that
the clinical definitions of “virulence” and “pathogenicity” are
themselves largely qualitative. In order to mitigate this caveat,
we therefore correlated our quantiative proteomic data with
over 700 gene expression models of TB disease—themselves
acquired under a number of different in vitro conditions that each
mimic in some way aspects of the stress likely to be experienced
by M. tuberculosis at the site of disease—in order to provide
a logical means to infer biological significance from in vitro
data with greater confidence. A testable prediction from the in
vitro quantitative proteomic data presented here is thus that
the observed differential expression of specific mycobacterial
proteins across these 7 strains when cultured under a common
set of environmental conditions will affect clinical phenotype in
vivo. However, the true role of these proteins in virulence will
need to be validated in due course by targeted analysis of limiting
numbers ofM. tuberculosis bacilli isolated from the site of disease.
CONCLUSION
Through our combined discovery- and quantitative proteomic
analysis of differential protein expression in 7 mycobacterial
strains of varying pathogenicity and virulence, we have
uncovered previously unknown, statistically significant
quantitative differences in the expression of numerous proteins
which begin to shed new light on differential virulence in M.
tuberculosis strains. In particular, our data suggests strain specific
bacterial fitness in the W-Beijing lineage, including: the ability
to rapidly remodel the M. tuberculosis proteome in response
to altered environments; up-regulation of key sigma factors
to support rapid transcriptional responses; up-regulation of
enzymes involved in pyrimidine biosynthesis and cell wall
biosynthesis to promote rapid growth; enhanced mycobactin
biosynthesis to promote iron scavenging in the host. These
individually selectable traits may then conceivably work together
to provide the W-Beijing lineage with an enhanced ability to
establish primary infection and active TB disease in a new host.
These are testable hypotheses and further research is underway
on this now.
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